May 22, 2009 - According to IMV’s recent census of cath labs in the U.S., starting in 2007 the total number of patient cases declined, with a 10 percent decline from 4.21 million in 2006 to 3.8 million in 2007, and a slight decrease of 1 percent to 3.75 million in 2008.
May 21, 2009 - Boston Scientific Corp. this week announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial.
May 22, 2009 – Biotronik said today it is partnering with Belgian biotechnology company Cardio3 BioSciences in its C-Cure stem cell clinical trial, where it will provide implantable cardioverter defibrillators (ICDs) with home monitoring.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 22, 2009 - New data presented yesterday at EuroPCR from an international, post-approval, single-arm study show that Abbott's XIENCE V Everolimus Eluting Coronary Stent System demonstrated low rates of repeat procedure (target lesion revascularization), stent thrombosis and major adverse cardiac events (MACE) in a complex patient population.
May 21, 2009 - LightLab Imaging Inc. this week is launching its next generation optical coherence tomography (OCT) system, the C7XR FD-OCT Imaging System with the C7 Dragonfly Imaging Catheter, at EuroPCR 2009 in Barcelona, Spain.
May 21, 2009 - Direct Flow Medical Inc. this week announced the first human use of its new 18 Fr. Percutaneous Aortic Valve (PAV) System, to successfully treat two high-risk surgical candidates at Dante Hospital in San Paolo, Brazil.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 21, 2009 - InspireMD Ltd. said today it completed enrollment for the MAGICAL Trial (MGuard in Acute Myocardial), which is designed to confirm the clinical feasibility, safety and performance of MGuard when used during primary PCI in STEMI patients.
May 21, 2009 – Edwards Lifesciences Corp. last week announced the successful completion of the first human implants of its next-generation transcatheter aortic heart valve used with its new 18 Fr. delivery system.
May 21, 2009 – Toshiba America Medical Systems Inc. introduced two advanced multidetector CT systems, the Aquilion Premium edition and the Aquilion CX edition. The Aquilion Premium provides an upgrade path to the Aquilion ONE, while the Aquilion CX is an advanced 64-detector row CT system that incorporates superior features of the existing Aquilion 64.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 20, 2009 – Lantheus Medical Imaging Inc. has signed an agreement with NTP Radioisotopes (Pty) Ltd., a subsidiary of the South African Nuclear Energy Corp. (NECSA), to manufacture and supply Lantheus with an ongoing volume of molybdenum-99 (Mo-99), a key isotope used in medical imaging procedures.
This comparison chart covers dedicated cardiac ultrasound scanners specifically intended for performing cardiac or vascular imaging studies. General purpose systems with extensive cardiac scanning options are also included.
To improve the diagnosis and treatment of patients with cardiovascular disease, Salinas Valley Memorial Healthcare System, an integrated healthcare network, wanted to create the Cardiovascular Diagnostic Center (CVDC) at its Ryan Ranch Outpatient facility in Monterey County, CA.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
In what some might argue is similar to the industry shake-out between Blu-ray and HD digital video disc technology, the competition between SPECT and PET cardiac imaging is heating up. And the marketing of existing radiotracers and the development of new nuclear imaging agents is reflective of both advances in technology and clinical trends.
Blood clots can occur almost anywhere in the body with potentially devastating implications. Typically, the first line of treatment for blood clots is drug therapy. Thrombolytic medications, such as tissue plasminogen activator (tPA), are approved for the immediate treatment of a clot in the brain (stroke) and for heart attack caused by a clot in a blood vessel of the heart.
Endovascular aneurysm repair (EVAR) using transcatheter-deployed stent grafts has grown significantly in the past 10 years. While surgeons traditionally perform aneurysm repairs, experts say the devices are increasingly deployed in cath labs by interventional cardiologists.